Dreamed Diabetes, Inc.

DreaMed Diabetes, is a developer of AI-based algorithms and data analytics focused on delivering expert-level care to all patients with diabetes. DreaMed's endo.digital platform is an FDA-cleared AI-based clinical decision support system which allows healthcare systems the ability to frequently monitor and optimize insulin dosing for patients across all care settings and improve patient outcomes. Endo.digital is currently being deployed at leading healthcare systems in the U.S.

HLTH does not sell or provide any personal data (including email, phone, address) to any third parties and we never will. Any communication that pretends to be HLTH or any third parties selling purported lists, discounted rooms, or any product/services are NOT AFFILIATED with HLTH and are to be considered FRAUD.

Upcoming Event Dates

2024 | ViVE: Feb 25-28; HLTH Europe: Jun 17-20; HLTH US: Oct 20-23

2025 | ViVE: Feb 16-19; HLTH US: Oct 19-22

2026 | HLTH US: Nov 15-18

2027 | HLTH US: Oct 17-20

© 2024 HLTH, INC. All Rights Reserved